Search for: "Aventis Pharmaceuticals, Inc."
Results 1 - 20
of 219
Sort by Relevance
|
Sort by Date
2 Aug 2023, 11:05 am
The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. [read post]
15 Jun 2023, 2:20 pm
See, e.g., Sanofi-Aventis Deutschland GmbH v. [read post]
25 May 2023, 6:00 am
Mylan Pharmaceuticals Inc., No. 2021-1981, 2023 U.S. [read post]
7 Feb 2023, 12:00 pm
HHS was whether HHS could require drug makers to provide discounted pharmaceutical to any number of contract pharmacies a covered entity chose to use. [read post]
17 Mar 2022, 2:32 pm
Mylan Pharmaceuticals Inc. [read post]
10 Nov 2021, 3:08 am
↑8 Id. at *13-14 (quoting Aventis Pharma S.A. v. [read post]
10 Nov 2021, 3:08 am
↑8 Id. at *13-14 (quoting Aventis Pharma S.A. v. [read post]
23 Sep 2021, 2:10 am
The US Courts of Appeal of the Federal Circuit (CAFC) found in Belcher Pharmaceuticals v Hospira, Inc that a formulation patent was unenforceable in view of inequitable conduct, in the form of contradictory submissions to the patent office and the regulatory agency (FDA) by the patentee. [read post]
12 Sep 2021, 9:59 pm
Amphastar Pharms., Inc., 525 F.3d 1334, 1349 (Fed. [read post]
9 Aug 2021, 2:22 pm
Scilex Pharmaceuticals Inc. v. [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
15 Apr 2021, 10:51 am
Sanofi-Aventis U.S. [read post]
14 Jan 2021, 4:40 pm
A $145 million settlement with EHR provider Practice Fusion, Inc., which was alleged to have accepted kickbacks from pharmaceutical companies including Purdue Pharma in exchange for implementing prompts in its EHR system that were designed to increase prescriptions of specific drugs. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
15 Oct 2020, 9:40 pm
Sanofi-Aventis U.S. [read post]
5 Oct 2020, 10:25 am
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
27 Sep 2020, 6:36 pm
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
